Biotechnology News

September 19, 2012

SHARSHERET, Israel--(BUSINESS WIRE)--Morflora (www.morflora.com), focused on innovative non-transgenic trait delivery technology for plant protection reports today that its TraitUP™...

September 19, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals initiates Phase 3 study of ZEVALIN in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).

September 19, 2012

JERUSALEM--(BUSINESS WIRE)--Gamida Cell, a leader in adult stem cell expansion technologies and products, announced today that it has completed enrollment for a Phase I/II clinical trial of NiCord, the company’s second pipeline product. NiCord is...

September 19, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today there will be a presentation on the mechanism of action of Capesaris® to induce sex hormone binding globulin (SHBG) and subsequently reduce free testosterone (FT) in men...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem appoints Louise Phanstiel to its Board of Directors.

September 19, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific, a leader in Assisted Reproductive Technologies (ART), announced that they have received 510k clearance for their Multipurpose Handling Medium™ product (MHM™) in the United States. The new MHM...

September 19, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals (OTCBB: PVCT) to Report Final Efficacy Data on Melanoma at ESMO 2012

September 19, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific, a global leader in Assisted Reproductive Technologies (ART), announced that they have received 510(k) clearance for their Continuous Single Culture™ - Complete product (CSCM-C). The company...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scientia Advisors appoints health economics, policy & reimbursement expert Randy Goodman Manager of Pricing and Market Access Group.

September 19, 2012

TAMPA BAY, Fla.--(BUSINESS WIRE)--News briefs concerning economic and business growth in the Tampa Bay region from the Tampa Bay Partnership.

September 19, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Initiates Talks to Acquire License for NASA Bioreactor Technology

September 19, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (publ.)(STO:RAYB) has entered into an exclusive license agreement with University Health Network’s Princess Margaret Cancer Centre in Toronto, Canada regarding techniques for...

September 19, 2012

CHICHESTER, England--(BUSINESS WIRE)--Proveris Scientific UK Limited expands operations and further executes on its commitment to serving the orally inhaled and spray drug product markets in Europe and Asia.

September 19, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (“Biomet”) announced an amendment to its previously announced tender offer (“Tender Offer”) to purchase for cash its outstanding 10% Senior Notes due 2017 (CUSIP Nos. 090613AC4; 550785AA7; U55004AA0) (...

September 18, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the three months ended...

September 18, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) today confirmed that it will cease repurchasing shares under the Normal Course Issuer Bid (NCIB) which will be cancelled effective as of September 19, after close of markets....

September 18, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Dividend

September 18, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the UBS Global Life Sciences Conference in New York. John F. Milligan, PhD, Gilead’s President and...

September 18, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Innovative microbiological bioburden testing system recognized at ABA’s First Tech and New Product Awards Ceremony in San Francisco

September 18, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Devon Medical Products has received approval from Medicare's Pricing, Data Analysis, and Coding (PDAC) contractor for its extriCARE™ 2400 Negative Pressure Wound Therapy (NPWT) pump and accessories.

September 18, 2012

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates announced it has been awarded a contract with NIDA to carry out clinical pharmacology studies to determine the pharmacokinetics & pharmacodynamics of new medications in humans.

September 18, 2012

TORONTO--(BUSINESS WIRE)--The US orthopedic soft tissue solutions market will be driven largely by a growing number of sports-related injuries.

September 18, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's 2012 CRO Quality Benchmarking report provides novel insight into the service quality of several Phase IV CROs.

September 18, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--A new, free white paper assists research institutions with the challenges of implementing biosafety level (BSL) 2+ practices and procedures in laboratory facilities.

September 18, 2012

SHREWSBURY, Mass.--(BUSINESS WIRE)--Join us in Cambridge, MA or Raleigh, NC to learn about small-scale single-use bioreactors coupled with continuous on-line measurement of glucose, viability, and more.

September 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales for schizophrenia therapies will drop from $7.4 billion in 2011 to $6.5...

September 18, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that rheumatologists in Germany and Spain indicated they have prescribed GlaxoSmithKline...

September 18, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/gnom) is investigating potential claims against the board of directors of...

September 18, 2012

COLUMBUS, Ohio--(BUSINESS WIRE)--Enlyton has secured funding from the National Cancer Institute for development of a novel imaging agent that will enable oncologists to produce more accurate scans in SPECT imaging of cancer.

September 18, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite medical publications’ importance to communicating key clinical data to the medical community, drug and device companies often track only volume-based metrics — leading to potentially missed...

September 18, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT), a provider of human therapeutic antibody technologies, today announced an agreement whereby Pfizer Inc., a global pharmaceutical company, will use OMT’s OmniRat™ for...

September 18, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Aptus Endosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration for its thoracic-length HeliFXTM Aortic Securement System.

September 18, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for plasticware and glassware – research

September 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it was awarded a contract from the U.S. Food and Drug Administration (FDA) to provide the agency with MiSeq sequencing systems and reagents for conducting whole genome...

September 18, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”) (OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that director of business development, Matthew Vincent, Ph.D., will be presenting at...

September 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals today announced that Yuchun Lee joined its board of directors as an independent director. Mr. Lee was appointed to the class of directors whose term expires in 2013.

September 18, 2012

MILAN--(BUSINESS WIRE)--European CE Mark approval for extended indications of Sorin's PERCEVAL S sutureless aortic valve, paving the way for adoption of Minimally Invasive Cardiac Surgery

September 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that interim results from the Company’s Phase 2b/3 GALAXY Trial will be presented at the European Society of Medical Oncology 2012 Congress held in...

September 18, 2012

DUBLIN, OHIO--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces Enrollment of First Subject in Phase 2 Trial of NAV4694 as an Aid in Diagnosing Alzheimer’s Disease

September 18, 2012

GREENVILLE, S.C.--(BUSINESS WIRE)--South Carolina Biotechnology Industry Organization (SCBIO) plans "What Next?" annual conference for biotech, health care and life sciences industry.

September 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori will give a corporate presentation and participate on a cell therapy panel discussion at the Noble Financial Capital Markets Life Sciences Exposition on September 24.

September 18, 2012

AUSTIN, Texas--(BUSINESS WIRE)--LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has launched a new, global corporate website. The website address (...

September 18, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Cenduit LLC continues to offer an unprecedented level of support for its clients with the appointment of John Cline as its Vice President of Client Services.

September 18, 2012

PORTLAND, Ore. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MolecularMD Corp. and ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that MolecularMD has voluntarily withdrawn its Premarketing Approval (PMA) application to the U.S. Food and...

September 18, 2012

KYOTO, Japan--(BUSINESS WIRE)--AB SCIEX and University of Wollongong collaborate on lipid analysis.

September 18, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm issued US composition of matter patent that provides protection for formulations of inhaled ciprofloxacin until 2031.

September 18, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b8w2pf/modern) has...

September 18, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals to Present at Society for Immunotherapy of Cancer Annual Meeting on October 26 & 27, 2012